Thames Capital Management LLC Takes Position in Ventas, Inc. $VTR

Thames Capital Management LLC bought a new stake in Ventas, Inc. (NYSE:VTR) during the fourth quarter, HoldingsChannel.com reports. The fund bought 61,830 shares of the real estate investment trust’s stock, valued at approximately $4,784,000.

A number of other institutional investors and hedge funds have also bought and sold shares of VTR. Norges Bank acquired a new position in Ventas in the 4th quarter valued at about $474,571,000. Vanguard Group Inc. grew its stake in Ventas by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after buying an additional 2,349,176 shares during the last quarter. UBS Group AG grew its stake in Ventas by 142.4% in the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after buying an additional 2,060,770 shares during the last quarter. Lasalle Investment Management Securities LLC grew its stake in Ventas by 1,135.1% in the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock valued at $108,686,000 after buying an additional 1,427,151 shares during the last quarter. Finally, PGGM Investments acquired a new position in Ventas in the 4th quarter valued at about $98,686,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Activity

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by insiders.

Ventas Stock Performance

Shares of NYSE:VTR opened at $84.55 on Friday. The company’s 50 day moving average price is $85.30 and its two-hundred day moving average price is $82.24. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The firm has a market cap of $41.10 billion, a PE ratio of 153.72, a PEG ratio of 1.86 and a beta of 0.74. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last announced its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company earned $0.84 EPS. The business’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is presently 378.18%.

Analyst Ratings Changes

A number of brokerages recently commented on VTR. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, May 4th. Wells Fargo & Company upped their price target on shares of Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. JPMorgan Chase & Co. upped their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Monday, May 11th. Morgan Stanley set a $90.00 price target on shares of Ventas in a research note on Friday, February 13th. Finally, Jefferies Financial Group upped their price target on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Ventas has an average rating of “Moderate Buy” and an average price target of $95.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.